Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-01

Clinical Trial Update: Effects of NSK-SD (Nattokinase) on Blood Pressure [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating NSK-SD (Nattokinase) for effects on blood pressure in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NSK-SD (Nattokinase)

Snippet

Sponsor: Natural Immune Systems Inc | Conditions: Hypertension | Phase 4 | Status: COMPLETED